368 related articles for article (PubMed ID: 11264253)
1. Cyclo-oxygenase and lipoxygenase pathways in mast cell dependent-neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve.
Le Filliatre G; Sayah S; Latournerie V; Renaud JF; Finet M; Hanf R
Br J Pharmacol; 2001 Apr; 132(7):1581-9. PubMed ID: 11264253
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
3. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
[TBL] [Abstract][Full Text] [Related]
4. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation.
Ohata A; Usami M; Miyoshi M
Nutrition; 2005; 21(7-8):838-47. PubMed ID: 15975492
[TBL] [Abstract][Full Text] [Related]
5. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
6. Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification.
Amann R; Schuligoi R; Peskar BA
Inflamm Res; 1999 Dec; 48(12):632-6. PubMed ID: 10669114
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
Lino RC; da Silva DPB; Florentino IF; da Silva DM; Martins JLR; Batista DDC; Leite KCS; Villavicencio B; Vasconcelos GA; Silva ALP; de Ávila RI; Verli H; Valadares MC; Gil ES; Vaz BG; Lião LM; Menegatti R; Costa EA
Eur J Pharm Sci; 2017 Aug; 106():231-243. PubMed ID: 28599988
[TBL] [Abstract][Full Text] [Related]
8. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat.
Parsadaniantz SM; Lebeau A; Duval P; Grimaldi B; Terlain B; Kerdelhué B
J Neuroendocrinol; 2000 Aug; 12(8):766-73. PubMed ID: 10929089
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.
Francischi JN; Chaves CT; Moura AC; Lima AS; Rocha OA; Ferreira-Alves DL; Bakhle YS
Br J Pharmacol; 2002 Nov; 137(6):837-44. PubMed ID: 12411415
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
11. Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation.
Kowalski ML; Sliwinska-Kowalska M; Kaliner MA
J Immunol; 1990 Aug; 145(4):1214-21. PubMed ID: 1696295
[TBL] [Abstract][Full Text] [Related]
12. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclooxygenase and lipoxygenase inhibition on basal- and serotonin-induced ion transport in rat colon.
Engelmann BE; Bindslev N; Poulsen SS; Hansen MB
Comp Biochem Physiol C Toxicol Pharmacol; 2002 May; 132(1):37-52. PubMed ID: 12039683
[TBL] [Abstract][Full Text] [Related]
14. Recent development in the field of dual COX / 5-LOX inhibitors.
Julémont F; Dogné JM; Pirotte B; de Leval X
Mini Rev Med Chem; 2004 Aug; 4(6):633-8. PubMed ID: 15279597
[TBL] [Abstract][Full Text] [Related]
15. Respective role of lipoxygenase and nitric oxide-synthase pathways in plasma histamine-induced macromolecular leakage in conscious hamsters.
Gimeno G; Carpentier PH; Desquand-Billiald S; Finet M; Hanf R
Br J Pharmacol; 1999 Apr; 126(8):1801-9. PubMed ID: 10372823
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
17. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
[TBL] [Abstract][Full Text] [Related]
18. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
19. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
[TBL] [Abstract][Full Text] [Related]
20. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II.
Oyekan A; Balazy M; McGiff JC
Am J Physiol; 1997 Jul; 273(1 Pt 2):R293-300. PubMed ID: 9249563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
